- Home
- MITT vs FENC Comparison
MITT vs FENC Comparison
Compare MITT & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MITT | FENC |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.9M | 230.8M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | MITT | FENC |
|---|---|---|
| Price | $7.68 | $10.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $9.25 | ★ $14.50 |
| AVG Volume (30 Days) | 187.6K | ★ 254.7K |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | ★ 11.96% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $44,642,000.00 |
| Revenue This Year | $3.48 | $65.12 |
| Revenue Next Year | $5.06 | $41.08 |
| P/E Ratio | ★ $9.34 | $1,070.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.86 | $5.65 |
| 52 Week High | $9.27 | $11.31 |
Technical Indicators
Market Signals| Indicator | MITT | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 42.52 | 65.34 |
| Support Level | $7.50 | $7.40 |
| Resistance Level | $7.97 | N/A |
| Average True Range (ATR) | 0.21 | 0.52 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 8.51 | 75.40 |
Price Performance
Historical ComparisonAbout MITT AG Mortgage Investment Trust Inc.
TPG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long term through dividends and capital appreciation. The company focuses on its investment activities on acquiring and securitizing newly-originated residential mortgage loans within the non-agency segment of the housing market.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.